Gene transfer during surgical procedures with molecular surgical suture

Abstract

Over the last decades, there has been an explosion of interest in plasmid DNA for gene therapy with reports of their efficacy in the fight against cancer, vascular diseases, and inherited diseases caused by specific gene defects (Srivastava, 2003). DNA plasmids present several advantages over the use of recombinant viruses concerning their production and safety issues. Plasmid DNA vectors can be constructed easily and economically, and they are free of size constraints imposed by viral packaging, obviating the need for an infectious vector and lessening the likelihood of toxicity and immunogenicity (Davis, 1993). Plasmids have a relative low cost, long shelf life and allow repetitive administration of the therapeutic gene without generating an immune response against the delivery vector (Donnelly, 2003). Finally, plasmids can be injected directly into tissues, such as heart (Sarkar, 2002), muscle (Neumeister, 2001, Dan, 2000) and tumors (De Marco, 2003, Sasaki, 2002).

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2009-06-29
Info
Issue
Section
Original Papers
Statistics
  • Abstract views: 273

  • PDF: 303
How to Cite
Huang, D., Yu, F., & Jingrong, L. J. (2009). Gene transfer during surgical procedures with molecular surgical suture. European Journal of Histochemistry, 48(2), 111-114. https://doi.org/10.4081/874